{"id":"W2897747244","doi":"10.1016/j.semarthrit.2018.10.006","title":"Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis","year":2018,"lang":"en","type":"article","venue":"Seminars in Arthritis and Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Seventh Framework Programme; Centre Hospitalier Universitaire de Clermont-Ferrand; Merck Sharp and Dohme; Institut National de la Santé et de la Recherche Médicale; AbbVie; Innovative Medicines Initiative; Illinois Department of Public Health; Pfizer","keywords":"Medicine; Infliximab; Adalimumab; Rheumatoid arthritis; Incidence (geometry); Drug; Internal medicine; Antirheumatic Agents; Retrospective cohort study; Antibody; Biosimilar; Immunology; Pharmacology; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002198746,0.0007338264,0.001142572,0.002188567,0.0005727884,0.001382424,0.0007967622,0.001406712,0.001981482],"category_scores_gemma":[0.003003315,0.001229149,0.003105558,0.003090771,0.00066369,0.00129674,0.0009978788,0.0007956143,0.0003569211],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005851073,"about_ca_system_score_gemma":0.0003905236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006561358,"about_ca_topic_score_gemma":0.003851122,"domain_scores_codex":[0.9972808,0.0009006669,0.0004893494,0.0008141404,0.000229977,0.0002850209],"domain_scores_gemma":[0.9966154,0.0008050722,0.001325694,0.0006196797,0.0003053676,0.0003289007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001029313,0.00004880689,0.9964605,0.00002362746,0.0008974025,0.0002222022,0.00007075955,0.00008308399,0.0002995715,0.00002457153,0.00006884693,0.000771173],"study_design_scores_gemma":[0.00005068465,0.0002004152,0.9979132,0.000009962845,0.0003420079,0.0008297686,0.0001815222,0.0002163074,0.00007524543,0.00001987779,0.0001464623,0.00001454758],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978219,0.001168747,0.0002099917,0.00001907446,0.00000892039,0.00001049003,0.0005629663,0.000004837183,0.0001930467],"genre_scores_gemma":[0.9983619,0.0003199349,0.0001908579,0.00003130962,0.00001765199,0.00001420327,0.0008810423,0.000005042612,0.0001780168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006561358,"threshold_uncertainty_score":0.01304638,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007683673004306536,"score_gpt":0.2620991952432041,"score_spread":0.2544155222388975,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}